-
The Scottish Medicines Consortium (SMC) accepts MYSODELLE® for use in NHS Scotland
inFerring Pharmaceuticals Ltd, U.K. announced today that the Scottish Medicines Consortium (SMC) has accepted its new product…
0 -
-
Ferring Pharmaceuticals and Roche collaborate to develop personalised infertility treatment
inFerring Pharmaceuticals and Roche have announced a collaboration to combine diagnostic testing technology from Roche with Ferring’s human cell…
-
Ferring launches Guts4life, an interactive online resource for people with inflammatory bowel disease
inFerring Pharmaceuticals marks World IBD Day (May 19th) with the launch of Guts4life (www.guts4life.com), a new interactive website with information…
-
New study suggests desmopressin melt improves sleep patterns and psychological functioning of bedwetting children
inNew data has shown that treatment with melt-in-the-mouth desmopressin (MINIRIN® Melt)* improved sleep patterns and psychological functioning…
-
Real-world patient survey data shows negative impact of nocturia
inNew patient survey data presented today at the European Association of Urology (EAU 14) congress, showed that nocturia…
-
MSD, Ferring Pharmaceuticals and the World Health Organization – Working Together to Prevent Excessive Bleeding in Women after Childbirth
inFerring Pharmaceuticals and MSD, known as Merck in the United States and Canada, today announced their collaboration with the World Health…
-
New paper indicates a potential fifty-percent reduction in cardiac events for prostate cancer patients with pre-existing cardiovascular disease when treated with FIRMAGON® (degarelix) compared to LHRH agonists
inA paper published today in European Urology, the official journal of the European Association of Urology, indicates that the gonadotropin…
-
Launch of CORTIMENT® (budesonide)
TIMELINES oninLorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
-
Ferring Pharmaceuticals appoints Alex Chang Senior Vice President, Asia Pacific
inFerring Pharmaceuticals announced today that it has appointed Alex Chang to head the company’s Asia Pacific region effective 1 November 2013…
Archiwum Autora pulse
Articles by: pulse